Main

Lawmakers worry FDA bill adds too much work (Federal Times)


Lawmakers worry FDA bill adds too much work (Federal Times)
A bipartisan group of legislators is concerned that a draft bill overhauling the Food and Drug Administration could cripple the agency by imposing a vast new workload.

FDA Obtains Permanent Injunction Against Scientific Laboratories, Inc. (U. S. Food and Drug Administration)
The U.S. Food and Drug Administration (FDA) today announced that Scientific Laboratories Inc., and its president, Rajeshwari Patel, and chief executive officer, Amit Roy, have signed a Consent Decree of Permanent Injunction and are barred from manufacturing and distributing drug products until they bring their manufacturing operations into compliance with law and obtain approval for their ...

FDA Approves Covidien System With RFID To Reduce Life-Threatening Errors (DataCollectionOnline)
Covidien (NYSE: COV, BSX: COV) recently announced that the U.S. Food and Drug Administration (FDA) has approved Covidien Imaging Solutions' contrast delivery system with radio-frequency identification (RFID) technology. The components integrate novel RFID technology to create a system that is designed to enhance patient safety by reducing the risk of medical errors in radiology departments.

Paragon CRT(R) Inquiries Increase with Recent FDA Hearing on Dangers


Paragon CRT(R) Inquiries Increase with Recent FDA Hearing on Dangers of LASIK (Centre Daily Times)
Paragon Vision Sciences announced a surge in inquiries for Paragon CRT(R) contact lenses, which gently reshape the cornea during sleep, temporarily correcting nearsightedness. The increase follows the April 25 FDA hearing regarding the dangers of LASIK surgery.

Arbios Receives Approval From The FDA To Initiate Pivotal Trial For SEPET(TM) Liver Assist Device (Medical News Today)
Arbios Systems, Inc. (OTC Bulletin Board: ABOS) announced that the Company has received approval from the U.S.
 
Notify me with the latest breaking FDA News
fda approvals Tell us where to send your notifications:

invivodata's ePRO Solution Captures Primary Efficacy Data Supporting Supplemental Approval


invivodata's ePRO Solution Captures Primary Efficacy Data Supporting Supplemental Approval of Sucampo's AMITIZA for a ... (Centre Daily Times)
invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that its ePRO solutions -- DiaryPRO(R) and SitePRO(R) -- captured primary efficacy data that supported the recent U.S. Food and Drug Administration's (FDA) supplemental approval of Sucampo Pharmaceutical Inc.'s AMITIZA(R) (lubiprostone) 8 mcg ...

I-Flow To Present At The Bank of America 2008 Health Care Conference on Tuesday, May 13, 2008 at 11:20 a.m. PDT (Centre Daily Times)
I-FLOW CORPORATION (NASDAQ:IFLO) announced today that it will address institutional shareholders at the Bank of America 2008 Health Care Conference on Tuesday morning, May 13, 2008 at 11:20 a.m. PDT.
 

©2006 FDA-News.com. All rights reserved.